Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors

Psycho-Oncology

Volumn 15, Issue 11, 2006, Pages 985-1000

  Alfano, Catherine M ^a   McGregor, Bonnie A ^a   Kuniyuki, Alan ^a   Reeve, Bryce B ^b   Bowen, Deborah J ^a   Baumgartner, Kathy B ^c   Bernstein, Leslie ^d   Ballard Barbash, Rachel ^b   Malone, Kathleen E ^a   Ganz, Patricia A ^e   McTiernan, Anne ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cancer; Hormone symptoms; Oncology; Psychometrics; Survivorship

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TENDERNESS; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COGNITIVE DEFECT; DYSPAREUNIA; EMOTIONAL STABILITY; FACTORIAL ANALYSIS; FEMALE; HOT FLUSH; HUMAN; INTERNAL CONSISTENCY; IRRITABILITY; MAJOR CLINICAL STUDY; MENOPAUSE; MENTAL HEALTH; MOOD CHANGE; NIGHT SWEAT; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SLEEP DISORDER; SYMPTOMATOLOGY; URINE INCONTINENCE; VAGINA DISCHARGE; VAGINAL PRURITUS; VALIDITY; VASOMOTOR DISORDER; WEIGHT GAIN;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA IN SITU; CLIMACTERIC; COMBINED MODALITY THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; SURVIVORS; TAMOXIFEN;

EID: 33751113536     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1033     Document Type: Article

References (26)

1. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. 2000. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18: 743-753.
2. Davison AC, Hinkley DV. 2003. Bootstrap Methods and Their Application. Cambridge University Press: Cambridge.
3. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham L, Fisher B. 1999. Health related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 17: 2659-2669.
4. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. 2000. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96: 351-358.
5. Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B. 1995. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 87: 1372-1382.
6. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. 1999. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 17: 2371-2380.
7. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. 2002. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 94: 39-49.
8. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. 2000. Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. J Natl Cancer Inst 92: 1054-1064.
9. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. 1998a. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16: 501-514.
10. Ganz PA, Rowland JH, Meyerowitz BE, Desmond KA. 1998b. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res 152: 396-411.
11. Goodwin PJ, Ennis M, Pritchard KI et al. 1999. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17: 120-129.
12. Greendale GA, Reboussin BA, Hogan P et al. 1998. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 92: 982-988.
13. Hays RD, Sherbourne CD, Mazel RM. 1993. The RAND 36-Item Health Survey 1.0. Health Econ 2: 217-227.
14. Hilditch JR, Lewis J, Peter A et al. 1996. A menopause-specific quality of life questionnaire: Development and psychometric properties. Maturitas 24: 161-175.
15. Hu LT, Bentler PM. 1999. Cutoff criteria for fit indices in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equation Modeling 6: 1-55.
16. Marchbanks PA, McDonald JA, Wilson HG et al. 2002a. The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and operational results. Ann Epidemiol 12: 213-221.
17. Marchbanks PA, McDonald JA, Wilson HG et al. 2002b. Oral contraceptives and the risk of breast cancer. N Engl J Med 346: 2025-2032.
18. Meeske K, Press M, Patel A, Bernstein L. 2004. Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer 110: 102-109.
19. Meyerowitz BE, Desmond KA, Rowland JH, Wyatt GE, Ganz PA. 1999. Sexuality following breast cancer. J Sex Marital Ther 25: 237-250.
20. Muthen LK, Muthen BO. 1998. Mplus User's Guide. Muthen and Muthen: Los Angeles, CA.
21. Patel AV, Press MF, Meeske K, Calle EE, Bernstein L. 2003. Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer 98: 2161-2169.
22. Rugo HS, Ahles T. 2003. The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research. Semin Oncology 30: 749-762.
23. SAS Institute. 2002. SAS OnlineDoc®, Version 9. SAS Institute Inc.: Cary, NC.
24. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C. 2002. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77: 479-487.
25. Stanton AL, Bernaards CA, Ganz PA. 2005. The BCPT Symptom Scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97(6): 448-456.
26. Ware JE Jr. 1996. The SF-36 health survey. In Quality of Life and Pharmacoeconomics in Clinical Trials. (2nd edn), Spilker B (ed.). Lippincott-Raven: Philadelphia; 337-345.